Zinbryta (daclizumab) / Biogen, AbbVie 
Welcome,         Profile    Billing    Logout  
 160 Diseases   4 Trials   4 Trials   682 News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zinbryta (daclizumab) / Biogen, AbbVie
2004-005055-33: Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay immunosuppression in comparison to current standard immunosuppression (mycophenolate mofetil, tacrolimus and continued corticosteroids) in renal transplantation.

Ongoing
4
180
Europe
Zenapax, Cellcept, Prograf, Rapamune, Ro 24-7375, Ro 106-1443, Not available, Zenapax, Cellcept, Prograf, Rapamune, Zenapax, Cellcept, Prograf, Rapamune
Barts and the London NHS Trust
Renal Transplantation
 
 
2005-003383-39: A randomized, open-label, multi-center study comparing a steroid sparing regimen versus standard steroid regimen in combination with daclizumab, mycophenolate mofetil and sirolimus in the prevention of acute renal allograft rejection.Estudio abierto, aleatorizado, multicéntrico, nacional, comparando un régimen libre de esteroides frente a un régimen de esteroides estándar, en combinación con Daclizumab, Micofenolato Mofetil y Sirolimus, en la prevención del rechazo agudo en trasplante renal.

Ongoing
4
144
Europe
Rapamune, Daclizumab, Rapamune, ZENAPAX, Rapamune, ZENAPAX
Roche Farma S.A.
Renal Transplant
 
 
2007-003023-20: TACROLIMUS – DACLIZUMAB - MYCOPHENOLATE MOFETIL IMMUNE PROPHYLAXISIN PEDIATRIC LIVER TRANSPLANTATION. An open, pilot, investigator-driven study in 20 recipients

Ongoing
4
50
Europe
Prograft, Cellcept, Zenapax, Prograft, Cellcept, Zenapax
Cliniques universitaires Saint-Luc
Liver transplantation
 
 
ACTRN12606000306516: Monotherapy Phase II Dose Ranging Study of DAC HYP in Relapsing Remitting Multiple Sclerosis

Not yet recruiting
2
264
 
Biogen Idec, Biogen Idec
Multiple Sclerosis
 
 

Download Options